Drug Discovery World

APRIL 14, 2023

Perhaps most significantly, Ghana accepted the R21/Matrix-M malaria vaccine for use in children, Moderna revealed that cancer vaccines could be ready by 2030, and a new treatment for long Covid fatigue could be available soon. The post This week in drug discovery (10-14 April) appeared first on Drug Discovery World (DDW).

Vaccine 130

Vaccine Clinical Trials Drugs Pharmaceutical Companies 130

Drug Discovery World

JANUARY 19, 2023

Worryingly, according to the United Nations, national climate plans for parties to the Paris Agreement would bring us back to 2010 emission levels, leading to a rise of around 11% in greenhouse gases by 2030. In fact, a 2019 study shows that the pharmaceutical industry generates around 48.55 degrees Celsius.

Pharmaceuticals 130

Pharmaceuticals Pharmaceutical Companies Clinical Trials Government 130

Drug Discovery World

JULY 14, 2023

The MOU reflects Lifera’s strategic mission to increase national resilience and grow the biopharma sector by enabling technology transfer, the creation of a skilled biopharmaceutical workforce and advancing Saudi Arabia’s Vision 2030.

Vaccine 130

Vaccine International Pharmaceuticals Marketing 130

The Pharma Data

MAY 31, 2022

The initiative is supported by a multidisciplinary Steering Committee of patient advocacy leaders, healthcare professionals, biosimilar experts and industry leaders from around the world, with a mission to increase global adoption of biosimilar medicines by at least 30% in 30+ countries by 2030.

Biosimilars 52

Biosimilars Treatment Government Hospitals 52

Drug Discovery World

DECEMBER 12, 2023

Exonate has now regained full rights to its complete portfolio of ophthalmology assets from Janssen Pharmaceuticals EXN407 is reportedly well placed to be the first topical treatment for retinal vascular diseases, including diabetic retinopathy and diabetic macular oedema. EXN407 is a small molecule inhibitor of splice factor kinase SRPK1.

Small Molecule 130

Small Molecule Trials Pharmacokinetics Treatment 130

The Pharma Data

MARCH 31, 2022

Bayer announced today that it is strengthening the production network of its pharmaceutical division to ensure sustainable competitiveness and support the transformation of its pharmaceutical business based on breakthrough innovation delivering long-term, sustainable business growth.

Production 52

Production Pharmaceuticals Science Therapies 52

Drug Discovery World

APRIL 10, 2023

India is traditionally known as ‘the pharmacy of the world’ due to its huge pharmaceuticals manufacturing capacity and high quantity of exports, particularly generic medicines and vaccines. It is emerging markets like India that analysts expect to spearhead the global growth of the pharmaceutical sector 1.

Vaccine 130

Vaccine Pharmaceuticals Drugs Science 130

Drug Discovery World

SEPTEMBER 5, 2022

In fact, the government is targeting over $50 billion in exports by 2030 and many international companies are accelerating efforts to deepen local supply networks. South Korea recovered from the pandemic earlier than many other Asian countries and reported rapid growth in its contract manufacturing industry in the last two years. .

International 130

International Government Marketing Drugs 130

DrugBank

MARCH 7, 2024

Pharmaceutical researchers, in particular, have a keen interest in understanding the unfolding dynamics of this market. adults using obesity medications by 2030, further underlining the growing significance of this sector. Let’s delve into what lies ahead in the coming year.

Pharmaceutical Companies 81

Pharmaceutical Companies Pharmaceuticals Clinical Trials Pharmacokinetics 81

PPD

OCTOBER 18, 2023

There has been an unprecedented expansion of different types of pharmaceutical therapies, as well as a change in the overall approach to health care. Continued expansion of the biotech industry is occurring in parallel, with an estimated compound annual growth rate of 13.96% from 2023-2030.

Laboratories 52

Laboratories Assay Development Small Molecule Packaging 52

The Pharma Data

MAY 15, 2023

Teva Shares Progress Toward Access to Medicines and Environmental Commitments, Meeting and Exceeding Several ESG Targets Ahead of Schedule Teva Pharmaceutical Industries Ltd. billion to hold us to our environmental and social targets—making Teva the largest SLB issuer in the pharmaceutical industry.

Government 40

Government Compliance Pharmaceuticals Production 40

DrugBank

MARCH 15, 2024

billion in 2022 and is projected to grow at a compound annual growth rate of 9.94% from 2023 to 2030. Eli Lilly's Triumph: Pioneering Solutions in Weight Management Eli Lilly's remarkable achievement with its drug Mounjaro (tirzepatide) in the fourth quarter of 2023 has sent ripples of excitement through the pharmaceutical industry.

Pharmaceutical Companies 69

Pharmaceutical Companies Pharmaceuticals Treatment Marketing 69

New Drug Approvals

JANUARY 31, 2024

The prevalence of non-alcoholic steatohepatitis (NASH), a form of NAFLD that is associated with hepatic inflammation and ballooning of hepatocytes, is expected to increase by 63% between 2015 and 2030 in the United States (Estes, Hepatology, 2018; 67(1): 123-133), where NASH is expected to become the leading cause of liver transplantation by 2020.

Treatment 52

Treatment Disease Pharmaceuticals Drugs 52

Drug Discovery World

OCTOBER 6, 2022

until 2030. According to Steve Bates OBE, Chief Executive of the BIA: “The UK is a global hub for life sciences, with a world leading academic base, global pharmaceutical players, an increasing manufacturing footprint and a thriving pipeline of innovative SMEs and entrepreneurs.” . Lu Rahman highlights some of the key players. .

Targeted Protein Degradation 130

Targeted Protein Degradation Drugs Pharma Companies Marketing 130

Drug Discovery World

FEBRUARY 10, 2023

Scandinavia represents one of the most exciting but perhaps underrepresented markets for the discovery and development of pharmaceuticals. Sweden remains Scandinavia’s powerhouse market for pharmaceutical research and development. Sweden remains Scandinavia’s powerhouse market for pharmaceutical research and development.

Science 130

Science Drugs Pharmaceutical Companies Pharmaceuticals 130

The Premier Consulting Blog

MAY 4, 2023

billion in 2022 and is expected to grow approximately eight percent from 2023 to 2030 [1]. At Premier Consulting, our team of pharmaceutical regulatory experts is helping clients understand the changing regulatory landscape related to ophthalmic drugs and devices. The global ophthalmic drugs market size was valued at $33.81

FDA 52

FDA Packaging Compliance Regulations 52

DrugBank

AUGUST 9, 2024

Investment Trends in Pharmaceutical Research and Development Investing in the pharmaceutical sector presents a unique set of challenges and opportunities; let’s examine them in more detail.  Pharmaceutical Market Analysis The global pharmaceutical market revenue in 2024 is projected to be 1.15

Pharmaceuticals 77

Pharmaceuticals Research Pharmaceutical Companies Clinical Trials 77

The Pharma Data

APRIL 7, 2021

Yet as challenging as 2020 was, it also brought us –Sanofi and the pharmaceutical industry– closer to our purpose than at any other time in living memory ,” said Hudson. In terms of energy management, all Sanofi sites will use 100% renewable electricity and the company has set a target of a carbon-neutral car fleet , both by 2030.

Packaging 52

Packaging Vaccine Disease Treatment 52

The Pharma Data

OCTOBER 9, 2021

Improvement Rectifier Designation is designed to accelerate the development and review of pharmaceuticals intended to treat serious or life- menacing conditions with prelusive testimonial that indicates they may demonstrate a substantial enhancement over available rectifiers that have entered full FDA imprimatur. trillion per space by 2030.

Disease 52

Disease FDA Therapies Testimonials 52

Vial

MAY 20, 2024

Within each of these, pharmaceutical and biotech sponsors are supported by preclinical and clinical contract research organizations (CROs) in clinical trials across various indications. billion by 2030 at a compound annual growth rate (CAGR) of 7.5% between 2024 and 2030. What is a Pre-Clinical CRO? over this period.

Clinical Research 52

Clinical Research Research Clinical Trials Laboratories 52

The Pharma Data

OCTOBER 14, 2021

Alzheimer’s is the most common form of dementia, which currently affects more than 55 million people worldwide, and is projected to reach 78 million by 2030. trillion per year by 2030. About Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives.

Disease 52

Disease Therapies FDA Trials 52

Vial

FEBRUARY 15, 2024

Pharmaceutical companies often face challenges in conducting clinical trials due to the need for substantial knowledge, time, and resources. over the forecast period (2022-2030). Clinical trials play a crucial role in advancing medical breakthroughs, but effective management is essential to unlock their full potential.

Pharma Companies 52

Pharma Companies Clinical Trials Compliance Trials 52

The Pharma Data

NOVEMBER 1, 2021

It further evolves Boehringer Ingelheim’s commitments and significantly increases the company’s impact on health, society, and environmental issues, in alignment with the United Nations 2030 Sustainable Development Goals. Boehringer Ingelheim’s commitment to MORE GREEN is underscored by a series of initiatives.

International 52

International Pharmaceuticals Therapies Pharmaceutical Companies 52

The Pharma Data

MAY 18, 2021

Sales at Pharmaceuticals were steady, and in the Consumer Health Division we performed better than the competition.” Pharmaceuticals: significant advances for Xarelto™ and Eylea™. EBITDA before special items at Pharmaceuticals declined by 6.0 The company confirmed the full-year outlook it issued in February 2021.

Science 40

Science Pharmaceuticals Production Marketing 40

Vial

MARCH 27, 2024

The Costs of Working with a CRO Running clinical trials is an integral part of the pharmaceutical industry, crucial to the development and approval of new drugs and treatments. from 2024 to 2030. These services range from clinical study design and data management to statistical analysis and regulatory support.

Clinical Trials 52

Clinical Trials Trials International Compliance 52

The Pharma Data

DECEMBER 1, 2020

Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021–2030 was endorsed by the Seventy-third World Health Assembly last week. She said achieving the 2030 goals will happen only with collaboration and coordination across sectors, with strong country ownership.

Vaccine 52

Vaccine Disease Government Science 52

The Pharma Data

FEBRUARY 21, 2022

At its annual Pharma Media Day 2022, Bayer presented the latest developments in the ongoing transformation of its pharmaceuticals business, which is aimed at delivering long-term, sustainable business growth by bringing forward new options for patients. “We

Small Molecule 52

Small Molecule Clinical Trials Clinical Development Production 52

The Pharma Data

FEBRUARY 22, 2022

Pascal Soriot, Chief Executive Officer, AstraZeneca, said: “ We are making great progress on our ambition to be zero carbon across our global operations by the end of 2025 and carbon negative across our entire value chain by 2030.

Science 52

Science Disease Pharmaceuticals Pharmaceutical Companies 52

The Pharma Data

JANUARY 26, 2021

The patent enters into force on 27 January 2021 and expires in 2030. The project portfolio is a combination of fully funded projects run in partnership with global pharmaceutical companies and innovative in-house projects with significant market and out-licensing potential. and are linked to the company’s project AD1503.

Disease 40

Disease Pharmaceutical Companies Licensing Licensing 40

Drug Discovery World

JULY 11, 2022

The global cell and gene therapy (CGT) market reached a value of ~$4 billion in 2020 and is expected to grow to ~$34 billion by 2030 1. For regulatory purposes, they may be treated more like a pharmaceutical or a blood product. In the United States, cell and gene therapies are viewed as innovative therapies by the FDA.

Therapies 130

Therapies Clinical Trials Production Trials 130

The Pharma Data

MARCH 2, 2021

ii It is projected that by 2030, close to half of the U.S. As a world-leading, research-driven pharmaceutical company, more than 51,000 employees create value through innovation daily for our three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. population will have obesity.

Treatment 52

Treatment Bioinformatics Clinical Development Therapies 52

Agency IQ

NOVEMBER 20, 2023

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has suggested that replacing certain paper product information with electronic versions has benefits for healthcare providers, regulatory agencies and patients. Realistically, paper product information could be phased out by 2030.

Production 40

Production Packaging Hospitals Regulations 40

Vial

FEBRUARY 8, 2024

To advance new therapies, pharmaceutical, biotech, and medical device companies engage contract research organizations (CROs) for their know-how in navigating the complex landscape of drug development and regulatory pathways and to run clinical trials. billion in 2030. How do CROs solve the challenges of managing clinical trials?

Clinical Trials 52

Clinical Trials Trials Clinical Research Research 52

Drug Discovery World

AUGUST 8, 2023

In the global pharmaceuticals market, India ranks third worldwide for production by volume and the domestic pharmaceutical market is expected to reach US$120-130 billion by 2030 1. Similarly, The Times of India says that branded generic medicines have “long fuelled India’s pharmaceutical exports” 4.

Research 130

Research Pharmacy Pharmaceuticals Government 130

The Pharma Data

AUGUST 5, 2021

percent to 2.577 billion euros, burdened by currency effects of 153 million euros / Crop Science posts strong sales growth, earnings impacted by higher costs and currency effects / Pharmaceuticals reports significant recovery after COVID-19 effects in prior year / Consumer Health continues growth momentum / Core earnings per share rise by 1.3

Production 52

Production Pharmaceuticals Science Therapies 52

The Pharma Data

NOVEMBER 22, 2020

About EZEPROGIND (AZP2006): Alzprotect is developing a drug candidate, EZEPROGIND, whose mode of action, acting on Progranulin secretion, is clearly different from other products developed in the past 15 years by the pharmaceutical industry. EZEPROGIND, which is kicking off phase 2a trials, is a bioavailable neurotrophic inducer.

Drugs 40

Drugs Disease Clinical Trials Licensing 40

Drug Discovery World

APRIL 25, 2024

billion in 2022, a figure that is expected to grow at a compound annual growth rate (CAGR) of 9.81% from 2023 to 2030 1. With the pharmaceutical sector increasingly focused on targeted treatments such as antibodies, developers will be more dependent on cell lines. He has a master’s degree in Journalism from Newcastle University.

Vaccine 148

Vaccine Production Pharmaceuticals Therapies 148